News

Newsletter November 2019

CHILI: Statistics, behind the scenes and a survey
Case: Neurolymphomatosis detected by 18F-FDG PET/CT
Webinar: PET/CT in infection and inflammation – Nov 20
Site Visit Video: PETSCAN ViennaPaper: Validated imaging biomarkers as decision-making tools
Webinar: Perfusion imaging: An update on clinical applications and relevance – Nov 27
News: Quality control tests for PET/MRI vary widely in Europe

Quality control tests for PET/MRI vary widely in Europe

Quality control tests for PET/MRI vary widely in Europe By Wayne Forrest, AuntMinnieEurope.com staff writer A survey of eight large European imaging facilities with extensive clinical experience of PET/MRI has found wide variations in daily quality control and...

Paper on validated imaging biomarkers

A paper on validated imaging biomarkers as decision-making tools in clinical trials and routine practice was published with the involvement of the ESHI research committee in Insights into Imaging.

Become part of the YOUNG ESHIᴹᵀ subcommittee!

Are you under 35 and excited about hybrid imaging?
Apply now for a committee position!

ESHIᴹᵀ endorses 10ps challenge: A step towards reconstruction-less TOF-PET

ESHIᴹᵀ is proud to announce that it endorses the lauch of a 10ps-Challenge to foster the next quantum leap in PET imaging and make reconstruction-less, high-sensitivity PET scanners a reality, thus paving the way towards reducing by an order of magnitude the radiation dose, the scan duration, and the scanning cost per patient.

Paper: State of affairs of hybrid imaging in Europe: two multi-national surveys

Integrated, interdisciplinary PET/CT reporting is not implemented ubiquitously. Training programmes and qualification options in hybrid imaging are limited in Europe.
Further harmonisation of operation and training in hybrid imaging is necessary on a European, regional and institutional level in order to ensure high clinical quality and to strengthen the clinical role of hybrid imaging.

Newsletter November 2019

CHILI: Statistics, behind the scenes and a survey
Case: Neurolymphomatosis detected by 18F-FDG PET/CT
Webinar: PET/CT in infection and inflammation – Nov 20
Site Visit Video: PETSCAN ViennaPaper: Validated imaging biomarkers as decision-making tools
Webinar: Perfusion imaging: An update on clinical applications and relevance – Nov 27
News: Quality control tests for PET/MRI vary widely in Europe

Quality control tests for PET/MRI vary widely in Europe

Quality control tests for PET/MRI vary widely in Europe By Wayne Forrest, AuntMinnieEurope.com staff writer A survey of eight large European imaging facilities with extensive clinical experience of PET/MRI has found wide variations in daily quality control and...

Paper on validated imaging biomarkers

A paper on validated imaging biomarkers as decision-making tools in clinical trials and routine practice was published with the involvement of the ESHI research committee in Insights into Imaging.

ESHIᴹᵀ endorses 10ps challenge: A step towards reconstruction-less TOF-PET

ESHIᴹᵀ is proud to announce that it endorses the lauch of a 10ps-Challenge to foster the next quantum leap in PET imaging and make reconstruction-less, high-sensitivity PET scanners a reality, thus paving the way towards reducing by an order of magnitude the radiation dose, the scan duration, and the scanning cost per patient.

Paper: State of affairs of hybrid imaging in Europe: two multi-national surveys

Integrated, interdisciplinary PET/CT reporting is not implemented ubiquitously. Training programmes and qualification options in hybrid imaging are limited in Europe.
Further harmonisation of operation and training in hybrid imaging is necessary on a European, regional and institutional level in order to ensure high clinical quality and to strengthen the clinical role of hybrid imaging.

Interview with ESHIᴹᵀ President Thomas Beyer on going hybrid

How is hybrid imaging faring across Europe, and are ongoing turf battles between radiology and nuclear medicine getting resolved?

Philipp Ward from AuntMinnie talked to Thomas Beyer, PhD, MBA, to reflect on these issues and on his first year as president of the European Society for Hybrid, Molecular and Translation Imaging (ESHIᴹᵀ), as well as the next 12 months ahead.